cl 64855 has been researched along with Disease Models, Animal in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brun, R; Jędrysiak, R; Kaiser, M; Suwiński, J; Torreele, E; Trunz, BB; Tweats, D | 1 |
Bisser, S; Bouteille, B; Chauvière, G; de Albuquerque, C; Dumas, M; Marie-Daragon, A; Périé, J; Rouillard, MC | 1 |
Bouteille, B; Chauvière, G; Dumas, M; Enanga, B; Keita, M | 1 |
Bouteille, B; Chauviere, G | 1 |
1 review(s) available for cl 64855 and Disease Models, Animal
Article | Year |
---|---|
[Use of megazol for the treatment of trypanosomiasis].
Topics: Acetanilides; Animals; Anti-Infective Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Metronidazole; Mice; Nitroimidazoles; Thiadiazoles; Trypanocidal Agents; Trypanosomiasis | 1999 |
3 other study(ies) available for cl 64855 and Disease Models, Animal
Article | Year |
---|---|
1-Aryl-4-nitro-1H-imidazoles, a new promising series for the treatment of human African trypanosomiasis.
Topics: Animals; Antiprotozoal Agents; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Leukocytes, Mononuclear; Mice; Molecular Structure; Mutagenicity Tests; Nitroimidazoles; Oxidation-Reduction; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Trypanosomiasis, African | 2011 |
[An efficacy trial on Trypanosoma brucei brucei of molecules permeating the blood-brain barrier and of megazol].
Topics: Africa South of the Sahara; Animals; Blood-Brain Barrier; Culture Media; Disease Models, Animal; Female; Free Radicals; Humans; Mice; Reactive Oxygen Species; Thiadiazoles; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African; World Health Organization | 1994 |
Megazol combined with suramin: a chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice.
Topics: Animals; Body Weight; Central Nervous System Diseases; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Humans; Immunohistochemistry; Mice; Recurrence; Suramin; Thiadiazoles; Time Factors; Trypanocidal Agents; Trypanosomiasis, African | 1998 |